Read + Share
ElHefnawi M, Jo E, Tolba MM, Fares M, et al. Drug repurposing through virtual screening and in vitro validation identifies
tigecycline as a novel putative HCV polymerase inhibitor. Virology 2022;570:9-17.
PMID: 35338891
|
 |
|
ElHefnawi M, Jo E, Tolba MM, Fares M, et al. Drug repurposing through virtual screening and in vitro validation identifies
tigecycline as a novel putative HCV polymerase inhibitor. Virology 2022;570:9-17.
PMID: 35338891
|
|
|
|